If these black marks on the industry are slowing down 31-year-old Vivek Ramaswamy in any way, you wouldn’t know it. He thinks his company, Roivant, will one day be a giant holding company for dozens of independent biopharmaceutical companies – both by developing drugs as well as focusing squarely on reducing the time and cost of the drug development process. It all sounds rather lofty.
Read More
Post by startupsnows.blogspot.com
No comments:
Post a Comment